A Biosafety Toolbox for Manufacturing with Single-Use Systems
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.New guidelines are needed for handling biohazardous materials in biological safety level 2 (BSL2) production. This includes assessing single-use solutions (SUSs) for safe manufacturing of novel therapies like viral vectors.
Area Of Science
- Biotechnology and Biopharmaceutical Manufacturing
- Biosafety and Risk Assessment
- Good Manufacturing Practice (GMP)
Background
- Growing recombinant biologicals market necessitates better risk assessment for biohazardous materials.
- Current practices may not adequately address safety for biological safety level 2 (BSL2) production, especially for viral vectors.
- Single-use solutions (SUSs) are prevalent but require adapted handling for BSL2 environments.
Purpose Of The Study
- To systematically assess technical solutions and best practices for biotechnological production using biohazardous materials up to BSL2.
- To develop new approaches for using SUSs in BSL2 production, ensuring product and staff safety.
- To provide information for safe and regulatory-aligned production of biologic therapies.
Main Methods
- Review of current GMP and best practices for biohazardous material handling.
- Analysis of safety considerations for SUSs in BSL2 environments.
- Examples of unpacking, storage, facility conditions, and staff training for SUS consumables.
Main Results
- Identified need for modified handling and design of SUS items for BSL2 production.
- Highlighted importance of facility conditions and staff training for safe SUS use.
- Provided examples of suitable SUS components and equipment for upstream and downstream processing.
Conclusions
- Safe and regulatory-aligned production of biologic therapies requires a comprehensive approach to SUS management in BSL2.
- Modified SUS design, handling protocols, facility integration, and staff training are crucial for BSL2 environments.
- This work offers essential information for stakeholders involved in BSL2 biomanufacturing.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.